The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-015-4719-xPMID 26733173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer.

  2014cited by this paper
• Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.

  2013cited by this paper
• Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5′-phosphatase interaction with c-Abl

  2013cited by this paper
• Long‐term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene

  2012cited by this paper
• VEGF-A/VEGFR-2 Signaling Plays an Important Role for the Motility of Pancreas Cancer Cells

  2012cited by this paper
• Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.

  2011cited by this paper
• Sunitinib for the treatment of metastatic renal cell carcinoma.

  2011cited by this paper
• Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.

  2011cited by this paper
• PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

  2011cited by this paper
• Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

  2011cited by this paper
• Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

  2011cited by this paper
• L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.

  2011cited by this paper
• Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.

  2011cited by this paper
• 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922

  2010cited by this paper
• Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.

  2010cited by this paper
• Abstract 63:TKTL1is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis via increased aerobic glycolysis and HIF1-alpha stabilization

  2010cited by this paper
• Phase II study of sunitinib in patients with metastatic urothelial cancer.

  2010cited by this paper
• Abstract 90: Mining for cancer causing mutations in whole genome sequence data

  2010cited by this paper
• Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

  2010cited by this paper
• HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors.

  2010cited by this paper
• Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

  2009cited by this paper
• Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

  2009cited by this paper
• Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer

  2009cited by this paper
• The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells

  2009cited by this paper
• Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor-κB

  2009cited by this paper
• Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition

  2009cited by this paper
• Green tea (-)-epigallocatechin gallate inhibits insulin stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway.

  2009cited by this paper
• Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

  2008cited by this paper
• Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers

  2008cited by this paper
• Sunitinib: from rational design to clinical efficacy.

  2007cited by this paper
• The combination of green tea and tamoxifen is effective against breast cancer.

  2006cited by this paper
• Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

  2006cited by this paper
• Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

  2006cited by this paper
• Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85α

  2006cited by this paper
• Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol.

  2005cited by this paper
• Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302*

  2004cited by this paper
• TSC2 regulates VEGF through mTOR-dependent and -independent pathways.

  2003cited by this paper
• Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice

  2003cited by this paper
• A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1

  2001cited by this paper
• Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

  2000cited by this paper
• Vascular endothelial growth factor as a marker of tumor endothelium.

  1998cited by this paper
• Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.

  1997cited by this paper
• Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

  1996cited by this paper
• Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

  1991cited by this paper
• Analysis of combined drug effects: a new look at a very old problem

  1983cited by this paper

• Preparation and Characterization of Corrosion-Resistant MgF2-PDA-EGCG Coatings on AZ31B Magnesium Alloy with Antibacterial and Osteoinductive Properties

  2025cites this paper
• A Review of the Relationship between Tea Drinking and Breast Cancer

  2025cites this paper
• Biomacromolecules as Immunomodulators: Utilizing Nature’s Tools for Immune Regulation

  2024cites this paper
• Steady-State Delivery and Chemical Modification of Food Nutrients to Improve Cancer Intervention Ability

  2024cites this paper
• Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

  2024cites this paper
• Immunomodulatory Effects of Green Tea Catechins and Their Ring Fission Metabolites in a Tumor Microenvironment Perspective

  2024cites this paper
• A self-healing coating with embedding of polyphenols on magnesium: Towards enhanced corrosion protection for biodegradable vascular implants

  2024cites this paper
• The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment

  2023cites this paper
• Mg alloy cardio-/cerebrovascular scaffolds: Developments and prospects

  2023cites this paper
• Flavonoids as receptor tyrosine kinase inhibitors in lung cancer

  2023cites this paper
• Impact of Polyphenolic Compounds on the MAPK Signaling Pathway against Carcinogenesis

  2023cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis

  2022cites this paper
• A Review of the Pharmacological Potential of Spatholobus suberectus Dunn on Cancer

  2022cites this paper
• Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.

  2022cites this paper
• The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells

  2022cites this paper
• Epigallocatechin 3-gallate: From green tea to cancer therapeutics.

  2022cites this paper
• Combinational Therapy Using Chemotherapeutic Agents and Dietary Bioactive Compounds

  2021cites this paper
• Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions

  2021cites this paper
• A novel technology to reduce astringency of tea polyphenols extract and its mechanism

  2021cites this paper
• Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma

  2021cites this paper
• Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways

  2021cites this paper
• Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.

  2021cites this paper
• Potential Bioactive Components and Health Promotional Benefits of Tea (Camellia sinensis).

  2020cites this paper
• nOnalcOhOlic liver steatOsis in rats fed a high-fat diet

  2020cites this paper
• Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer

  2020cites this paper
• Preclinical Pharmacological Activities of Epigallocatechin ‐ 3 ‐ gallate in Signaling Pathways :

  2020cites this paper
• Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.

  2020cites this paper
• The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.

  2020cites this paper
• Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action

  2020cites this paper
• The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment

  2020cites this paper
• Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy

  2020cites this paper
• Chemical Structures and Pharmacological Profiles of Ginseng Saponins

  2019cites this paper
• Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy

  2019cites this paper
• Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy

  2018cites this paper
• Natural compounds and combination therapy in colorectal cancer treatment.

  2018cites this paper
• Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer

  2018cites this paper
• Phytotherapeutics in cancer invasion and metastasis

  2018cites this paper
• Modulation of cisplatin cytotoxic activity against leiomyosarcoma cells by epigallocatechin-3-gallate

  2018cites this paper
• Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism

  2017cites this paper
• Guaraná, a Highly Caffeinated Food, Presents in vitro Antitumor Activity in Colorectal and Breast Cancer Cell Lines by Inhibiting AKT/mTOR/S6K and MAPKs Pathways

  2017cites this paper
• Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems

  2017cites this paper
• Phytotherapy and Nutritional Supplements on Breast Cancer

  2017cites this paper
• Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats

  2017cites this paper
• Overview of Locally Advanced Breast Cancer: A Huge Challenge to Science

  2017cites this paper
• Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer

  2017influential citation
• Effect of Tea Polyphenol Compounds on Anticancer Drugs in Terms of Anti-Tumor Activity, Toxicology, and Pharmacokinetics

  2016cites this paper
• Therapeutic effects of EGCG: a patent review

  2016cites this paper